10.500
+0,00%
2026-10-13
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +9.9% | -3.6% | 1 / 3 | +57.9% | +0.75 pp | -0.73 pp | +11.1% | 0.17 | 6.32 | 149 | +57,9% | 2,5 | +9,9% | 6.32 | 7.49 | −15,6% |
| Pts | 0 | 0 | 4 | 12 | 8 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 10.500 (close price on 2026-10-13)EPS (TTM): 1.662
Financial charts
1.Revenue & growth
VND bn149Q2/26
1.Revenue & growth
VND bn149Q2/26
2.Profit & growth
VND bn2,50Q2/26
3.Profit mix (Penman)
VND bn10,1Q2/26
4.Margins & cost structure
%9.2%Q2/26
5.Returns & cash cycle
% · days14.4%Q2/26
6.Earnings quality & cash
VND bn8,15Q2/26
7.Asset structure
VND bn120Q2/26
8.Funding & debt health
VND bn · times120Q2/26
9.Revenue backlog
VND bn14,7Q2/26
10.Valuation
times · %6,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %521Q2/26
Adjusted EPS growth, latest quarter
9.9%
Average adjusted EPS growth, 3 quarters
-3.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26